Case Report

Hair loss due to pregabaline: a case report

Volume: 3 Number: 3 December 31, 2020
EN TR

Hair loss due to pregabaline: a case report

Abstract

The Ministry of Health in Turkey approved the use of pregabalin at 150-600 mg/day doses in peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia and as adjunctive therapy in adult patients with partial epilepsy. Hair loss is rarely seen among psychotropic drugs. This side effect is most frequently reported in mood stabilizers among psychotropic agents. In this case, we aimed to present a case of common hair loss, which was not seen in the literature before, occurred after starting pregabalin treatment and resolved only by discontinuation of treatment.

Keywords

References

  1. 1. Stahl SM. Anticovulsants and relief of cranic pain: pregabalin anda gabapentin as alpha(2)delta ligands at voltage-gated calcıum channels. J Clin Psychiatry 2004;65:596-7.
  2. 2. Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert opin Investing Drugs 2003;12:663-72.
  3. 3. Orwin A: Hair loss following lithium therapy. Br J Dermatol 1983;108:503-4.
  4. 4. Öztürkcan S, Ateş M. Alopecia and drugs. Türkderm 2014; 48: Özel Sayı 1: 48-51.
  5. 5. Headington JT: Telogen effluvium. New concepts and review. Arch Dermatol 1993;129: 356–363.
  6. 6. Harrison S, Bergfeld W: Diffuse hair loss: its triggers and management. Cleve Clin J Med 2009;76:361-7.
  7. 7. Mansi Patel, Shannon Harrison, Rodney Sinclair: Drugs and Hair Loss. Dermatol Clin 2013;31:67-73.
  8. 8. Tosti A, Pazzaglia M: Drug reactions affecting hair: diagnosis. Dermatol Clin 2007;25:223-31.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Case Report

Publication Date

December 31, 2020

Submission Date

October 15, 2020

Acceptance Date

December 23, 2020

Published in Issue

Year 2020 Volume: 3 Number: 3

APA
Turgut, C., & İzki, A. A. (2020). Hair loss due to pregabaline: a case report. Medical Research Reports, 3(3), 41-45. https://izlik.org/JA58YZ64ZK
AMA
1.Turgut C, İzki AA. Hair loss due to pregabaline: a case report. MRR. 2020;3(3):41-45. https://izlik.org/JA58YZ64ZK
Chicago
Turgut, Celaleddin, and Alparslan Ali İzki. 2020. “Hair Loss Due to Pregabaline: A Case Report”. Medical Research Reports 3 (3): 41-45. https://izlik.org/JA58YZ64ZK.
EndNote
Turgut C, İzki AA (December 1, 2020) Hair loss due to pregabaline: a case report. Medical Research Reports 3 3 41–45.
IEEE
[1]C. Turgut and A. A. İzki, “Hair loss due to pregabaline: a case report”, MRR, vol. 3, no. 3, pp. 41–45, Dec. 2020, [Online]. Available: https://izlik.org/JA58YZ64ZK
ISNAD
Turgut, Celaleddin - İzki, Alparslan Ali. “Hair Loss Due to Pregabaline: A Case Report”. Medical Research Reports 3/3 (December 1, 2020): 41-45. https://izlik.org/JA58YZ64ZK.
JAMA
1.Turgut C, İzki AA. Hair loss due to pregabaline: a case report. MRR. 2020;3:41–45.
MLA
Turgut, Celaleddin, and Alparslan Ali İzki. “Hair Loss Due to Pregabaline: A Case Report”. Medical Research Reports, vol. 3, no. 3, Dec. 2020, pp. 41-45, https://izlik.org/JA58YZ64ZK.
Vancouver
1.Celaleddin Turgut, Alparslan Ali İzki. Hair loss due to pregabaline: a case report. MRR [Internet]. 2020 Dec. 1;3(3):41-5. Available from: https://izlik.org/JA58YZ64ZK